UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 59

Sortiert nach

Nectin-4: a new prognostic biomarker for efficient therapeutic targeting of primary and metastatic triple-negative breast cancer

Annals of oncology, 2017-04, Vol.28 (4), p.769-776

2017

Volltextzugriff (PDF)

Gene expression profiling of breast cell lines identifies potential new basal markers

Oncogene, 2006-04, Vol.25 (15), p.2273-2284

2006

Volltextzugriff (PDF)

Junctional recruitment of mammalian Scribble relies on E-cadherin engagement

Oncogene, 2005-06, Vol.24 (27), p.4330-4339

2005

Volltextzugriff (PDF)

ERBB2 phosphorylation and trastuzumab sensitivity of breast cancer cell lines

Oncogene, 2007-11, Vol.26 (50), p.7163-7169

2007

Volltextzugriff (PDF)

Correlated break at PARK2/FRA6E and loss of AF-6/Afadin protein expression are associated with poor outcome in breast cancer

Oncogene, 2007-01, Vol.26 (2), p.298-307

2007

Volltextzugriff (PDF)

CXCR1 blockade selectively targets human breast cancer stem cells in vitro and in xenografts

The Journal of clinical investigation, 2010-02, Vol.120 (2), p.485-497

2010

Volltextzugriff (PDF)

Cellules souches du cancer du sein : prendre le cancer à la racine

Oncologie (Paris, France), 2012-09, Vol.14 (9), p.543-549

2012

Volltextzugriff (PDF)

Cellules souches du cancer du sein: prendre le cancer à la racine: L'anatomie pathologique en 2012 : évolution et perspectives

Oncologie (Paris, France), 2012, Vol.14 (9), p.543-549

2012

Volltextzugriff (PDF)

Gene expression profiling of colon cancer by DNA microarrays and correlation with histoclinical parameters

Oncogene, 2004-02, Vol.23 (7), p.1377-1391

2004

Volltextzugriff (PDF)

Abstract P2-10-02: AVASTEM – Stem cells inhibition by bevacizumab in combination with neoadjuvant chemotherapy for locally advanced breast cancers: A prospective proof of concept randomized phase II trial

Cancer research (Chicago, Ill.), 2019-02, Vol.79 (4_Supplement), p.P2-P2-10-02

2019

Volltextzugriff (PDF)

S17 Breast cancer stem cells: Getting to treat the core

Breast (Edinburgh), 2009, Vol.18, p.S7-S8

2009

Volltextzugriff (PDF)

Protein expression profiling identifies subclasses of breast cancer and predicts prognosis

Cancer research (Chicago, Ill.), 2005-02, Vol.65 (3), p.767-779

2005

Volltextzugriff (PDF)

Comprehensive Profiling of 8p11-12 Amplification in Breast Cancer

Molecular cancer research, 2005-12, Vol.3 (12), p.655-667

2005

Volltextzugriff (PDF)

Abstract P5-06-02: Ex vivo CSC assays for personalized testing of drug susceptibility in advanced breast cancer

Cancer research (Chicago, Ill.), 2018-02, Vol.78 (4_Supplement), p.P5-P5-06-02

2018

Volltextzugriff (PDF)

Immunophenotypic analysis of inflammatory breast cancers: identification of an 'inflammatory signature'

The Journal of pathology, 2004-03, Vol.202 (3), p.265-273

2004

Volltextzugriff (PDF)

Reciprocal translocations in breast tumor cell lines: Cloning of a t(3;20) that targets the FHIT gene

Genes chromosomes & cancer, 2002-11, Vol.35 (3), p.204-218

2002

Volltextzugriff (PDF)

Identification and validation of an ERBB2 gene expression signature in breast cancers

Oncogene, 2004-04, Vol.23 (14), p.2564-2575

2004

Volltextzugriff (PDF)

27 INVITED ALDH1 is a marker of normal and cancer breast stem cells and a predictor of poor clinical outcome

European journal of cancer supplements, 2007, Vol.5 (4), p.11-11

2007

Volltextzugriff (PDF)

TACC1-chTOG-Aurora A protein complex in breast cancer

Oncogene, 2003-11, Vol.22 (50), p.8102-8116

2003

Volltextzugriff (PDF)

Distinct and Complementary Information Provided by Use of Tissue and DNA Microarrays in the Study of Breast Tumor Markers

The American journal of pathology, 2002-10, Vol.161 (4), p.1223-1233

2002

Volltextzugriff (PDF)

Abstract P4-13-23: Next-generation sequencing (NGS), array comparative genomic hybridization (aCGH) and patient-derived tumor xenograft (PDX) for precision medicine in advanced breast cancer: A single-center prospective study

Cancer research (Chicago, Ill.), 2016-02, Vol.76 (4_Supplement), p.P4-P4-13-23

2016

Volltextzugriff (PDF)

A recurrent chromosome breakpoint in breast cancer at the NRG1/Neuregulin 1/Heregulin gene

Cancer research (Chicago, Ill.), 2004-10, Vol.64 (19), p.6840-6844

2004

Volltextzugriff (PDF)

P1-04-07: Poly (ADP-Ribose) Polymerase-1 (PARP-1) Is Overexpressed in Human Breast Cancer Stem Cells: Results from a Proteomic-Based Approach

Cancer research (Chicago, Ill.), 2011-12, Vol.71 (24_Supplement), p.P1-P1-04-07

2011

Volltextzugriff (PDF)

Basal and luminal breast cancers: basic or luminous? (review)

International journal of oncology, 2004-08, Vol.25 (2), p.249

2004

Volltextzugriff (PDF)

Le tissu microarray outil de recherche et/ou de routine dans le cadre des cancers du sein

Oncologie (Paris, France), 2006-03, Vol.8 (3), p.267-268

2006

Volltextzugriff (PDF)

1 – 25 von 59

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(51)
Mit Volltextzugriff
(47)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Nectin-4: a new prognostic biomarker for efficient therapeutic targeting of primary and metastatic triple-negative breast cancer

Gene expression profiling of breast cell lines identifies potential new basal markers

Junctional recruitment of mammalian Scribble relies on E-cadherin engagement

ERBB2 phosphorylation and trastuzumab sensitivity of breast cancer cell lines

Correlated break at PARK2/FRA6E and loss of AF-6/Afadin protein expression are associated with poor outcome in breast cancer

CXCR1 blockade selectively targets human breast cancer stem cells in vitro and in xenografts

Cellules souches du cancer du sein : prendre le cancer à la racine

Cellules souches du cancer du sein: prendre le cancer à la racine: L'anatomie pathologique en 2012 : évolution et perspectives

Gene expression profiling of colon cancer by DNA microarrays and correlation with histoclinical parameters

Abstract P2-10-02: AVASTEM – Stem cells inhibition by bevacizumab in combination with neoadjuvant chemotherapy for locally advanced breast cancers: A prospective proof of concept randomized phase II trial

S17 Breast cancer stem cells: Getting to treat the core

Protein expression profiling identifies subclasses of breast cancer and predicts prognosis

Comprehensive Profiling of 8p11-12 Amplification in Breast Cancer

Abstract P5-06-02: Ex vivo CSC assays for personalized testing of drug susceptibility in advanced breast cancer

Immunophenotypic analysis of inflammatory breast cancers: identification of an 'inflammatory signature'

Reciprocal translocations in breast tumor cell lines: Cloning of a t(3;20) that targets the FHIT gene

Identification and validation of an ERBB2 gene expression signature in breast cancers

27 INVITED ALDH1 is a marker of normal and cancer breast stem cells and a predictor of poor clinical outcome

TACC1-chTOG-Aurora A protein complex in breast cancer

Distinct and Complementary Information Provided by Use of Tissue and DNA Microarrays in the Study of Breast Tumor Markers

Abstract P4-13-23: Next-generation sequencing (NGS), array comparative genomic hybridization (aCGH) and patient-derived tumor xenograft (PDX) for precision medicine in advanced breast cancer: A single-center prospective study

A recurrent chromosome breakpoint in breast cancer at the NRG1/Neuregulin 1/Heregulin gene

P1-04-07: Poly (ADP-Ribose) Polymerase-1 (PARP-1) Is Overexpressed in Human Breast Cancer Stem Cells: Results from a Proteomic-Based Approach

Basal and luminal breast cancers: basic or luminous? (review)

Le tissu microarray outil de recherche et/ou de routine dans le cadre des cancers du sein

Suchergebnisse filtern